Glucotrack has announced the receipt of St Vincent’s Hospital Melbourne Human Research Ethics Committee’s (HREC) approval for ...

Emma Gill had bee been warned about her blood sugar levels being too high before, so she tested out a continuous glucose ...

Glucotrack (Nasdaq:GCTK) announced today that it received a hospital's ethical approval to study its continuous blood glucose ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert on the circulation of ...

Injectable medications, specifically glucagon-like peptide-1 receptor agonists (GLP-1 medications) — are helping people manage blood sugar, support weight loss, and improve overall well-being.

Blood glucose monitoring systems and related consumables were provided at no cost by Ascensia Diabetes Care, while the IfDT covered the remaining costs. No funding was provided by the ...

Related: FDA warns Dexcom over continuous glucose monitor testing Venture capital firm Alpha Wave Ventures led the round with participation from RiverVest Venture Partners, AXA IM Alts ...

BD is rolling out a new monitoring platform equipped with artificial-intelligence-powered programs that aim to predict potentially life-threatening changes in the patient’s blood pressure during ...

During the monitoring process, nursing staff applied the standard blood glucose meter (Accu-Chek ® Performa Connect) and utilized the same batch of blood glucose test strips for fingertip blood ...

Their approach, based on continuous glucose monitoring (CGM) data, could improve early detection and risk assessment for diabetes without relying on blood samples and expensive or complex procedures.